Skip to content

Clinical trials

Muscular Atrophy, Spinal trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Atrophy, Spinal Country / region: Belgium Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20153
20163
20171
20183
20191
20211
20225
20233
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting6
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche7
Novartis Pharmaceuticals4
Biogen3
Scholar Rock, Inc.3
Centre Hospitalier Universitaire de Liege2
Biohaven Pharmaceuticals, Inc.1
Centre Hospitalier Régional de la Citadelle1
Institut de Myologie, France1
NMD Pharma A/S1
Novartis Gene Therapies1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Atrophy, Spinal24
Muscular Atrophy5
Neuromuscular Diseases4
Spinal Muscular Atrophies of Childhood4
Bulbo-Spinal Atrophy, X-Linked3
Muscular Diseases3
Neuromuscular Manifestations3
Atrophy2
Motor Neuron Disease1
Muscular Dystrophy, Duchenne1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.